Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation.

MLA

Yahaya, M. A. F., et al. “Insights from Molecular Docking and Molecular Dynamics on the Potential of Vitexin as an Antagonist Candidate against Lipopolysaccharide (LPS) for Microglial Activation in Neuroinflammation.” BMC Biotechnology, vol. 21, no. 1, June 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12896-021-00697-4.

APA

Yahaya, M. A. F., Bakar, A. R. A., Stanslas, J., Nordin, N., Zainol, M., & Mehat, M. Z. (2021). Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation. BMC Biotechnology, 21(1), 1–10. https://doi.org/10.1186/s12896-021-00697-4

Chicago

Yahaya, M. A. F., A. R. Abu Bakar, J. Stanslas, N. Nordin, M. Zainol, and M. Z. Mehat. 2021. “Insights from Molecular Docking and Molecular Dynamics on the Potential of Vitexin as an Antagonist Candidate against Lipopolysaccharide (LPS) for Microglial Activation in Neuroinflammation.” BMC Biotechnology 21 (1): 1–10. doi:10.1186/s12896-021-00697-4.